RYBELSUS (Novo Nordisk)
(https://rybelsus.com) πΈ Data Snapshot: June 19, 2026Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Authority is the weakest pillar due to a total absence of structured data, with schema_json returning null on every page. There is a disconnect between the brand’s global pharma status and its technical implementation, which lacks Organization or Medication schema. Furthermore, the use of a testimonial figure Troy standing with his dog lacks any Person schema or digital authority footprint to verify his status as a real patient. The technical implementation also suffers from minor issues like duplicate H2 headings (RYBELSUSβAll of This in 1 Pill) on the Results page.
The site’s performance claims are strictly bound to clinical study results rather than marketing hyperbole. For every claim of efficacy, such as lowered blood sugar better, the site provides the average starting A1C (8.3%) and the specific delta for each dose. This level of transparency is rare and demonstrates high substance. There are no bold claims of life-changing transformations that aren’t immediately qualified by individual results may vary.
Identity & Authority is read from the structured data first: whether the site declares who it is in machine-readable schema, with verifiable identity links. Below is the schema captured per page, then the external proof links that support (or fail to support) that identity.
π Identity & Technical Layer β schema JSON-LD: identity chains, entity gaps
π‘οΈ Trust Signals β external proof links that back the declared identity
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 0 |
| /why-rybelsus/rybelsus-results.html | 0 | 0 |
| /why-rybelsus/rybelsus-vs-other-diabetes-pills.html | 0 | 0 |
| /why-rybelsus.html | 0 | 0 |
This page presents a snapshot of public data from RYBELSUS (Novo Nordisk), captured on June 19, 2026, to show how machine logic reads Identity & Authority signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to RYBELSUS (Novo Nordisk): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://rybelsus.com to view the most current version of its content and see directly what this company is about and what it offers.